Us was Insmed’s largest region in fiscal 2025, bringing in $452.95M of $606.42M (75%).
| Geography | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Us | $185.99M | $224.20M | $254.80M | $452.95M | ||
| International | — | $81.01M | $108.91M | $153.47M | ||
| Japan | $56.51M | — | — | — | ||
| Europe & Rest Of World | $2.86M | — | — | — | ||
| Total | $245.36M | $305.21M | $363.71M | $606.42M |
Insmed brought in $606.42M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 66.7% from $363.71M in fiscal 2024. Us was the largest at $452.95M (74.7%), ahead of International at $153.47M (25.3%).
Compared with fiscal 2024, Us grew 77.8% to $452.95M and International grew 40.9% to $153.47M.
Insmed began breaking out International in fiscal 2023, when it brought in $81.01M. Insmed stopped reporting Japan ($56.51M in fiscal 2022) and Europe & Rest Of World ($2.86M in fiscal 2022) as separate regions.
Arikayce was Insmed’s largest product and service line in fiscal 2025, bringing in $433.77M of $606.42M (72%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Arikayce | $305.21M | $363.71M | $433.77M |
| Brinsupri | — | — | $172.66M |
| Total | $305.21M | $363.71M | $606.42M |
Insmed brought in $606.42M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Insmed regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $363.71M. Arikayce was the largest at $433.77M (71.5%), ahead of Brinsupri at $172.66M (28.5%).
Insmed began breaking out Brinsupri in fiscal 2025, when it brought in $172.66M.
Insmed (INSM) reports its revenue by geography and by product and service. In fiscal 2025, Us was its largest region, bringing in $452.95M (74.7% of the total), followed by International at $153.47M (25.3%).
Us was Insmed's largest region in fiscal 2025, bringing in $452.95M, or 74.7% of the $606.42M total across its two regions.
Arikayce was Insmed's largest product and service line in fiscal 2025, bringing in $433.77M, or 71.5% of the $606.42M total across its two product and service lines.
Us grew faster than International in fiscal 2025, up 77.8% from $254.80M to $452.95M. International grew 40.9% to $153.47M.
Every figure comes from Insmed's annual financial filings, as reported. Each line keeps the name Insmed gives it, and years follow its fiscal calendar.
Insmed's revenue by geography goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.